Suchergebnisse - "Taxonera, Carlos"

PubPharm (217)

1

Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease : A National, Multicentre Study Based on ENEIDA Registry

enthalten in: Journal of Crohn's & colitis | 2024

von Casas Deza, D. | Polo Cuadro, C. | de Francisco, R. | +47

2

Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents : data from the ENEIDA registry

enthalten in: Therapeutic advances in gastroenterology | 2024

von Calafat, M. | Torres, P. | Tosca-Cuquerella, J. | +56

3

Meta-analysis : Real-world effectiveness and safety of ustekinumab in patients with ulcerative colitis

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Taxonera, C. | Olivares, D. | López-García, O. | +1

4

Meta‐analysis : Real‐world effectiveness and safety of ustekinumab in patients with ulcerative colitis

enthalten in: Alimentary Pharmacology & Therapeutics | 2023

von Taxonera, C. | Olivares, D. | López‐García, O. | +1

5

Risk Factors for COVID-19 in Inflammatory Bowel Disease : A National, ENEIDA-Based Case-Control Study (COVID-19-EII)

enthalten in: Journal of clinical medicine | 2022

von Zabana, Y. | Marín-Jiménez, I. | Rodríguez-Lago, I. | +83

6

Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients : The SUSTAIN Study

enthalten in: Inflammatory bowel diseases | 2022

von Chaparro, M. | Baston-Rey, I. | Fernández-Salgado, E. | +64

7

Editorial : golimumab thresholds to achieve stringent medium- and long-term therapeutic outcomes in patients with ulcerative colitis-Author's reply

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Taxonera, C.

CommentOn: Aliment Pharmacol Ther. 2022 Aug;56(4):614-624. - PMID 35509152

8

Association of golimumab trough concentrations during maintenance with clinical, biological, endoscopic and histologic remission in patients with ulcerative colitis

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Taxonera, C. | Fernández-Aceñero, M. | Olivares, D. | +12

CommentIn: Aliment Pharmacol Ther. 2022 Aug;56(4):735-736. - PMID 35879902

9

Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab

enthalten in: Journal of clinical medicine | 2022

von Chaparro, M. | Baston-Rey, I. | Fernández Salgado, E. | +65

10

Recommendations for the detection of latent tuberculosis infection in patients with immune-mediated inflammatory diseases candidates for anti-TNF therapy may not be applicable in all settings

enthalten in: Rheumatology international | 2022

von Taxonera, C. | Olivares, D. | Alba, C.

CommentOn: Rheumatol Int. 2022 Aug;42(8):1443-1451. - PMID 34228162

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]